The short version

What it is: the US version of Nurosym, an ear clip from London-based Parasym that sends a mild current through the tragus (the flap in front of your ear canal) toward a branch of the vagus nerve. Parasym says it's the same device and technology under a different name.
Price (as of October 2026): $900, often with $90 to $100 off for completing an online assessment or research survey. No subscription. A 2-year warranty, 6 months on the earpiece. HSA/FSA possible through Truemed.
FDA status: not FDA-cleared or approved. In the US it's sold as a general wellness product.
Best for: people who can sit with it for up to an hour a day and care most about published research.
Skip it if: you're pregnant, have a very slow resting heart rate, have a pacemaker or other implant, or have a piercing near the ear you can't remove. With heart disease, ask your doctor first.
The honest take: backed by more published research than any rival ear device, much of it in heart conditions. The stress and sleep claims rest on small studies, and the US site stretches them further.

The site that keeps sending you somewhere else

It's 2:50am and you've finally looked up the ear clip a woman in your Facebook group swears by. She called it Nurosym. But the website keeps steering you to something called Nuropod. Same photos, same studies, different name, $900. Is it a knockoff? A rebrand?

It's a rebrand, and the backstory is worth knowing before you buy.

What it is and how it works

Nuropod is a palm-sized control unit with buttons, an earpiece on a cable, a charger and a travel case. You dampen your left tragus with a drop of water, clip the earpiece on, set a timer and raise the level until you feel a light tingle. Parasym suggests sessions of 15 to 60 minutes, not while sleeping or exercising. Its US site says one charge lasts "weeks," though Parasym's Nurosym help center says up to about a week. A free companion app offers check-ins and tips but doesn't connect to the device. For ear versus neck devices, see the Zappers.

Parasym says Nuropod and Nurosym are the same device and technology, sold under different names in different markets. Owners and Tom's Guide describe them as identical. Our Nurosym review covers the European version.

Why Nurosym isn't sold in the US

Parasym hasn't said exactly why. Here's what the record shows:

2022 to 2023: one Reddit user wrote in May 2022 that Nurosym had started shipping to the US. By May 2023, US buyers on Reddit said the Nurosym site wouldn't ship to them.
Mid-2023 to mid-2024: archived copies of nurosym.com from July 2023 to June 2024 carry a footer saying Nurosym "is an investigational device in the United States." In FDA terms, an investigational device is one being studied in research, not one cleared for sale.
July 2024: by mid-July 2024, the site's country list marked the US "not available now," and it still does.
July 2025: the Nuropod store was live at $900 by July 23, 2025, the day its iPhone app came out. Trade press covered the US launch on September 4, 2025.
Parasym's explanation: it says it created Nuropod because Nurosym wasn't available in the US, with a "regulatory framework tailored to the local conditions."

The upshot: in Europe, the technology is sold as a CE-marked medical device. In the US, Nuropod's app listing says the app and device "are not medical devices." Same clip, different rules.

What the evidence actually says

Nuropod's site cites more than 60 completed studies and says it was "scientifically studied in the United States" with Harvard, UCLA and Penn. Some of that is solid. Some is stretched.

What holds up. NIH-funded, double-blind trials at the University of Oklahoma used Parasym's device against a sham clipped to the earlobe. In 53 people with paroxysmal atrial fibrillation, time in that irregular rhythm was 85% lower than with sham after six months. In 26 women with POTS, heart rate rose about 18 beats a minute on standing, versus 32 with sham. Small, but real.

What's thinner. The stress, fatigue and sleep numbers come from small studies with no comparison group: 24 women with long COVID over 10 days, 20 long COVID patients over 10 days, 18 people with fibromyalgia over four weeks. The study closest to most readers' question gave 68 adults from the general public a Parasym device for two weeks. Sleep improved, but not significantly more than with an earlobe sham.

What's stretched.

Nuropod's homepage describes a one-hour session improving HRV by 61% against placebo. Nurosym's homepage describes the same kind of session as an 18% improvement. The paper Parasym cites for the session gave 14 students five minutes of stimulation.
Its "FDA Non-Significant Risk Designation" is, under FDA rules, a judgment about the risk of a research study, usually made by an ethics board. It isn't permission to market the device.
Press quotes on the Nuropod site from 2023 and 2024 articles name "Nuropod." The same quotes on Nurosym's site name Nurosym, and Nuropod didn't launch until 2025.

Ear stimulation is promising but early, and expectation is powerful. For how to read studies like these, see the Science.

What owners commonly report

US feedback is thin. As of October 2026, Nuropod has no Trustpilot reviews and no Better Business Bureau profile. Its app averages 2.4 stars from 12 ratings, with reviewers calling it pointless and buggy. On Reddit:

The good: some owners say it calms them, eases POTS symptoms or gut cramping, or helps them sleep, often alongside other treatment. They like that it's hands-free.
The not so good: the earpiece is hard to keep in place on a small tragus. Several owners noticed nothing after a month or more, including some tracking HRV. One felt lightheaded at a low setting.
Returns: one owner said they were still out about $90 after returning it. Another said their return request went unanswered.

The European version scores 4.2 on Trustpilot from about 1,350 reviews, with similar earpiece complaints.

Price, returns and HSA/FSA (as of October 2026)

Device: $900, shipped free from California. Discounts of 10% or $100 come and go.
Extras: a spare earpiece is $50.
Returns: the refund policy gives 30 days from delivery. You must email first, then buy a prepaid label through Parasym's portal. The device must be clean, undamaged and in its original packaging with every accessory. Elsewhere the site says refunds close 37 days after your order date, so I'd count from the order.
Warranty: 2 years on the device, 6 months on the earpiece.
HSA/FSA: checkout offers Truemed. You fill in a health survey and an independent clinician decides whether to issue a letter of medical necessity. Truemed says better sleep alone, without a specific condition, doesn't meet the IRS bar.

How it compares

US prices as of October 2026:

Xen by Neuvana ($359 on sale): earbuds that stimulate inside the ear canal, 15 minutes a day, HSA/FSA through Truemed.
ZenoWell ($239 to $439): an earbud, 20-minute sessions, no published trials of its own.
Pulsetto (Lite $242): a neckband with gel, one small company-funded study, app upsells.
Truvaga ($325 or $499): a handheld neck device, two minutes a session, from the maker of a prescription headache device.

Nuropod has more research than any of them. It also costs two to four times as much.

Who should skip it or ask a doctor first

Parasym says Nuropod isn't suitable if you've had your vagus nerve surgically cut, have a severely low resting heart rate, have a metal or electronic implant or jewelry near the tragus that can't be removed, or are pregnant. With a pacemaker or other active implant, metal implants, severe coronary disease or a heart attack in the past five years, it says to use it only under a health professional's supervision. Its FAQ adds a history of trigeminal neuralgia, and contradicts the product page by saying people with pacemakers shouldn't use it at all.

Listed side effects include skin irritation and, early on, occasional nausea or headache. Its trials changed heart rhythm and blood pressure, so if you take heart or blood pressure medication, or faint easily, ask first. And if palpitations are new, or arrived with perimenopause, get them checked before you call it stress.

Try this free tonight

Try cyclic sighing for five minutes: breathe in through your nose, take a second short sip of air on top, then let it all out slowly through your mouth. In a 2023 Stanford study of 108 adults, five minutes a day for a month improved mood more than mindfulness meditation. It works lying down at 3am. More no-cost options are in the Analogs.

FAQ

Is Nuropod the same as Nurosym?

Parasym says yes: same technology and device, sold as Nuropod in the US, Canada, Australia and New Zealand, and as Nurosym in the UK and Europe.

Is Nuropod FDA approved?

No. It isn't FDA-approved or cleared. It's sold as a general wellness product, and its "non-significant risk" designation relates to research studies, not sales.

Is Nuropod HSA/FSA eligible?

Possibly, through Truemed at checkout, if an independent clinician approves a letter of medical necessity. Approval isn't guaranteed.

Does Nuropod work?

For heart conditions such as atrial fibrillation and POTS, small sham-controlled trials are encouraging. For everyday stress and sleep, the best trial we found showed no clear advantage over sham. Some owners do report real benefits.

The bottom line

Nuropod is the most researched ear clip sold in the US, and its heart trials are genuine science. But the US site leans on wellness rules while borrowing medical-sounding claims, and at $900 the stress and sleep evidence is thin.

If you buy one, use it daily from the day it arrives, keep every scrap of packaging, and decide before day 30. Keep the free breathing going either way. Your 3am brain deserves gentleness, and a little skepticism too.

Nuropod